Literature DB >> 11874207

EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum.

P Rojas1, B Garduño, C Rojas, R M Vigueras, J Rojas-Castañeda, C Rios, N Serrano-Garcia.   

Abstract

EGb761 has been suggested to be an antioxidant and free radical scavenger. Excess generation of free radicals, leading to lipid peroxidation (LP), has been proposed to play a role in the damage to striatal neurons induced by 1-methyl-4-phenylpyridinium (MPP+). We investigated the effects of EGb761 pretreatment on MPP+ neurotoxicity. C-57 black mice were pretreated with EGb761 for 17 days at different doses (0.63, 1.25, 2.5, 5 or 10 mg/kg) followed by administration of MPP+, (0.18, 0.36 or 0.72 mg/kg). LP was analyzed in corpus striatum at 30 min, 1 h, 2 h and 24 h after MPP+ administration. Striatal dopamine content was analyzed by HPLC at the highest EGb761 dose at 2 h and 24 h after MPP+ administration. MPP+-induced LP was blocked (100%) by EGb761 (10 mg/kg). Pretreatment with EGb761 partially prevented (32%) the dopamine-depleting effect of MPP+ at 24 h. These results suggest that supplements of EGb761 may be effective at preventing MPP+-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11874207     DOI: 10.1023/a:1013971524150

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain.

Authors:  P Chan; L E DeLanney; I Irwin; J W Langston; D Di Monte
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

2.  Short-term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Authors:  P Rojas; C Ríos
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

3.  Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation.

Authors:  I B Afanas'ev; A I Dorozhko; A V Brodskii; V A Kostyuk; A I Potapovitch
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

4.  Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7.

Authors:  H Kobuchi; M T Droy-Lefaix; Y Christen; L Packer
Journal:  Biochem Pharmacol       Date:  1997-03-21       Impact factor: 5.858

5.  Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids.

Authors:  M Joyeux; A Lobstein; R Anton; F Mortier
Journal:  Planta Med       Date:  1995-04       Impact factor: 3.352

6.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

7.  Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  L Y Zang; H P Misra
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

8.  In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection.

Authors:  W J Triggs; L J Willmore
Journal:  J Neurochem       Date:  1984-04       Impact factor: 5.372

Review 9.  Flavonoids, a class of natural products of high pharmacological potency.

Authors:  B Havsteen
Journal:  Biochem Pharmacol       Date:  1983-04-01       Impact factor: 5.858

Review 10.  MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Authors:  M Gerlach; P Riederer; H Przuntek; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-12-12       Impact factor: 4.432

View more
  2 in total

1.  EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.

Authors:  Patricia Rojas; Carolina Rojas; Manuchair Ebadi; Sergio Montes; Antonio Monroy-Noyola; Norma Serrano-García
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

2.  Ginkgo biloba extract in an animal model of Parkinson's disease: a systematic review.

Authors:  K Tanaka; R F S- Galduróz; L T B Gobbi; J C F Galduróz
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.